George Sellers

Stock Analyst at Stephens & Co.

(1.07)
# 3,900
Out of 5,130 analysts
44
Total ratings
29.41%
Success rate
-6.87%
Average return

Stocks Rated by George Sellers

Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115$145
Current: $112.92
Upside: +28.41%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $68.34
Upside: -0.50%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275$290
Current: $112.81
Upside: +157.07%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56$58
Current: $38.56
Upside: +50.41%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151$178
Current: $137.07
Upside: +29.86%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.50
Upside: +152.63%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $29.68
Upside: +142.59%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8$5
Current: $3.49
Upside: +43.27%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $2.90
Upside: +762.07%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $22.12
Upside: +157.69%